InvestorsHub Logo
Followers 242
Posts 12276
Boards Moderated 0
Alias Born 08/14/2003

Re: None

Thursday, 12/07/2023 1:56:21 PM

Thursday, December 07, 2023 1:56:21 PM

Post# of 1106
More success with an IMGN developed product.

https://finance.yahoo.com/news/press-release-sarclisa-isatuximab-phase-063500551.html

I'm frankly uncertain how great IMGN's financial interest is in this, but clearly it's a greater indication of the value of their technology, and further indication that the buyout offer is too low.

I'm purchasing some out of the money future calls in hope that we'll get a better offer.

Gary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IMGN News